Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaofang Che

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Cancer Management and Research|July 17, 2019
M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancerLili Cao, Xiaofang Che, Xueshan Qiu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 11, 2025
Targeting Intratumoral Bacteria for Cancer TreatmentJianbin Shi, Jiaqi Liang, Yi Li, et al.
Oncotarget|August 6, 2016
MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cellsQian Dong, Ce Li, Xiaofang Che, et al.
Frontiers in Oncology|May 12, 2020
5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer PatientsMin Zhang, Yibo Fan, Xiaofang Che, et al.
Phytotherapy Research : PTR|July 26, 2019
β-Elemene inhibits peritoneal metastasis of gastric cancer cells by modulating FAK/Claudin-1 signalingMingming Deng, Ye Zhang, Bofang Liu, et al.
Translational Oncology|June 9, 2016
A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line ChemotherapyJin Wang, Jinglei Qu, Zhi Li, et al.
Oncology Reports|March 23, 2018
SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancerLu Xu, Xiaofang Che, Ying Wu, et al.
International Immunopharmacology|May 11, 2020
TGFB2 serves as a link between epithelial-mesenchymal transition and tumor mutation burden in gastric cancerBoWen Yang, Jin Bai, Ruichuan Shi, et al.
International Journal of Molecular Medicine|July 3, 2015
Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptorsLei Zhao, Shizhou Liu, Xiaofang Che, et al.
Biomarkers in Medicine|October 27, 2017
Combination of platelet count and neutrophil-lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancerJin Wang, Jinglei Qu, Zhi Li, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Cancer Management and Research|July 17, 2019
M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancerLili Cao, Xiaofang Che, Xueshan Qiu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 11, 2025
Targeting Intratumoral Bacteria for Cancer TreatmentJianbin Shi, Jiaqi Liang, Yi Li, et al.
Oncotarget|August 6, 2016
MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cellsQian Dong, Ce Li, Xiaofang Che, et al.
Frontiers in Oncology|May 12, 2020
5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer PatientsMin Zhang, Yibo Fan, Xiaofang Che, et al.
Phytotherapy Research : PTR|July 26, 2019
β-Elemene inhibits peritoneal metastasis of gastric cancer cells by modulating FAK/Claudin-1 signalingMingming Deng, Ye Zhang, Bofang Liu, et al.
Translational Oncology|June 9, 2016
A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line ChemotherapyJin Wang, Jinglei Qu, Zhi Li, et al.
Oncology Reports|March 23, 2018
SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancerLu Xu, Xiaofang Che, Ying Wu, et al.
International Immunopharmacology|May 11, 2020
TGFB2 serves as a link between epithelial-mesenchymal transition and tumor mutation burden in gastric cancerBoWen Yang, Jin Bai, Ruichuan Shi, et al.
International Journal of Molecular Medicine|July 3, 2015
Bufalin inhibits TGF-β-induced epithelial-to-mesenchymal transition and migration in human lung cancer A549 cells by downregulating TGF-β receptorsLei Zhao, Shizhou Liu, Xiaofang Che, et al.
Biomarkers in Medicine|October 27, 2017
Combination of platelet count and neutrophil-lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancerJin Wang, Jinglei Qu, Zhi Li, et al.
Pageof 12